Learn more

CIPLA LTD

Overview
  • Total Patents
    1,740
  • GoodIP Patent Rank
    4,173
  • Filing trend
    ⇧ 18.0%
About

CIPLA LTD has a total of 1,740 patent applications. It increased the IP activity by 18.0%. Its first patent ever was published in 1988. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are SIPLA LTD, NEURODERM LTD and LULLA AMAR.

Patent filings per year

Chart showing CIPLA LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Malhotra Geena 809
#2 Rao Dharmaraj Ramachandra 624
#3 Kankan Rajendra Narayanrao 621
#4 Lulla Amar 426
#5 Pathi Srinivas Laxminarayan 157
#6 Purandare Shrinivas Madhukar 153
#7 Phull Manjinder Singh 124
#8 Hamied Yusuf Khwaja 77
#9 Rao Xerxes 70
#10 Geena Malhotra 70

Latest patents

Publication Filing date Title
WO2021044437A1 Olaparib co-crystals and process of preparation thereof
WO2020217259A1 Methods and systems for simulating deposition of inhaled drug on lungs
WO2020202192A1 Pharmaceutical combination formulations comprising tizanidine, resveratrol and piperine
WO2020161744A1 Novel polymorphs of integrase inhibitor
WO2020129085A1 Intranasal formulation
WO2020115774A1 High drug load extended release formulations
US2020155556A1 Stable pharmaceutical formulations of pemetrexed
WO2020079706A1 Pharmaceutical formulation
WO2020075196A1 Polymorphs of n-(4-(6,7-dimethoxyquinolin-4-yloxy) phenyl)-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide, (s)- malate, methods of production and pharmaceutical uses thereof
WO2020065667A1 Novel polymorphs of acalabrutinib, a bruton's tyrosine kinase inhibitor
AU2019339644A1 Single blister-strip based dispenser
WO2020049598A2 Apalutamide polymorphs
WO2019239432A1 Trisodium sacubitril valsartan complex and hot-melt extruded pharmaceutical composition comprising thereof
US2019350844A1 Depot formulation
WO2019211877A1 Process for the preparation of macrocyclic ketone analogs of halichondrin b
WO2019211870A1 Polymorphic forms of ibrutinib
EP3773731A1 Pharmaceutical formulations
WO2019167068A1 Novel polymorphs of ribociclib succinate
WO2019159199A1 Continues flow process for the preparation of active pharmaceutical ingredients - polycyclic carbamoyl pyridone derivatives and intermediates thereof
WO2019142214A1 Pharmaceutical composition comprising tiotropium for inhalation